• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Flutamide withdrawal and concomitant initiation of aminoglutethimide in patients with hormone refractory prostate cancer.

作者信息

Figg W D, Dawson N, Middleman M N, Brawley O, Lush R M, Senderowicz A, Steinberg S H, Tompkins A, Reed E, Sartor O

机构信息

Clinical Pharmacology Branch, National Cancer Institute, National Institute of Health, Bethesda, Maryland, USA.

出版信息

Acta Oncol. 1996;35(6):763-5. doi: 10.3109/02841869609084015.

DOI:10.3109/02841869609084015
PMID:8938230
Abstract
摘要

相似文献

1
Flutamide withdrawal and concomitant initiation of aminoglutethimide in patients with hormone refractory prostate cancer.在激素难治性前列腺癌患者中停用氟他胺并同时开始使用氨鲁米特。
Acta Oncol. 1996;35(6):763-5. doi: 10.3109/02841869609084015.
2
Response of carcinoma of the prostate to withdrawal of flutamide.前列腺癌对氟他胺撤药的反应。
Br J Urol. 1993 Nov;72(5 Pt 1):662-3. doi: 10.1111/j.1464-410x.1993.tb16234.x.
3
Phase II study of suramin plus aminoglutethimide in two cohorts of patients with androgen-independent prostate cancer: simultaneous antiandrogen withdrawal and prior antiandrogen withdrawal.舒拉明联合氨鲁米特治疗两组雄激素非依赖性前列腺癌患者的II期研究：同时停用抗雄激素药物与先前已停用抗雄激素药物。
Clin Cancer Res. 1998 Jan;4(1):37-44.
4
Surprising activity of flutamide withdrawal, when combined with aminoglutethimide, in treatment of "hormone-refractory" prostate cancer.氟他胺撤药联合氨鲁米特治疗“激素难治性”前列腺癌时的惊人疗效。
J Natl Cancer Inst. 1994 Feb 2;86(3):222-7. doi: 10.1093/jnci/86.3.222.
5
The antiandrogen withdrawal syndrome. Experience in a large cohort of unselected patients with advanced prostate cancer.抗雄激素撤药综合征。一大群未经选择的晚期前列腺癌患者的经验。
Cancer. 1995 Oct 15;76(8):1428-34. doi: 10.1002/1097-0142(19951015)76:8<1428::aid-cncr2820760820>3.0.co;2-t.
6
The antiandrogen withdrawal syndrome in relapsed prostate cancer.
Eur Urol. 1997;31 Suppl 2:3-7; discussion 24-7. doi: 10.1159/000474540.
7
The use of flutamide as a single antiandrogen treatment for hormone-refractory prostate cancer.
BJU Int. 2003 Nov;92(7):695-8. doi: 10.1046/j.1464-410x.2003.04479.x.
8
Hormone and antihormone withdrawal: implications for the management of androgen-independent prostate cancer.
Urology. 1996 Jan;47(1A Suppl):61-9. doi: 10.1016/s0090-4295(96)80011-2.
9
Intermittent androgen suppression--ready for prime time?
J Urol. 2012 Jun;187(6):1956-7. doi: 10.1016/j.juro.2012.03.034. Epub 2012 Apr 11.
10
Finasteride and flutamide therapy in patients with advanced prostate cancer: response to subsequent castration and long-term follow-up.非那雄胺和氟他胺治疗晚期前列腺癌患者：对后续去势治疗的反应及长期随访
Urology. 2003 Jul;62(1):99-104. doi: 10.1016/s0090-4295(03)00145-6.

引用本文的文献

1
Antiandrogen withdrawal syndrome associated with prostate cancer therapies: incidence and clinical significance.与前列腺癌治疗相关的抗雄激素撤药综合征：发生率及临床意义。
Drug Saf. 2000 Nov;23(5):381-90. doi: 10.2165/00002018-200023050-00003.